• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于软件的靶向前列腺活检中刚性与弹性配准方法的比较:一项多中心队列研究

Comparison of rigid and elastic registration methods in software-based targeted prostate biopsy: a multicenter cohort study.

作者信息

Çetin Serhat, Çelik Serdar, Koparal Murat Yavuz, Aslan Güven, Yazici Sertaç, Şahin Bahadır, Sözen Sinan, Türkeri Levent

机构信息

Department of Urology, Faculty of Medicine, Gazi University, Ankara, Turkiye.

Department of Urology, Faculty of Medicine, University of Health Sciences, Bozyaka Training and Research Hospital, İzmir, Turkiye.

出版信息

Turk J Med Sci. 2024 Sep 3;54(6):1327-1334. doi: 10.55730/1300-0144.5916. eCollection 2024.

DOI:10.55730/1300-0144.5916
PMID:39734338
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11673674/
Abstract

BACKGROUND/AIM: This study aims to compare the success rates of rigid registration (RR) and elastic registration (ER) systems in diagnosing all cancers and clinically significant prostate cancer (csPC) in software-based targeted prostate biopsies (TPBs) by performing matching analysis.

MATERIALS AND METHODS

The data of 2061 patients from six centers where software-based TPB is performed were used. All cancer and csPC detection rates of the RR and ER systems were compared following Mahalanobis distance matching with the propensity score caliper method. Logistic regression analysis was applied to identify factors predicting clinically insignificant prostate cancer (ciPC) and csPC diagnoses. Additionally, the International Society of Urological Pathology Grade Group (ISUP GG) upgrade rates of RR and ER systems were compared between biopsy and radical prostatectomy pathologies.

RESULTS

The matched sample included 157 RR and 157 ER patients. No statistically significant difference was found between ER and RR in terms of csPC detection rate (28.0% vs. 22.3% respectively, p = 0.242). The detection rate of all cancers by ER compared to RR was found to be significantly higher (54.8% vs. 35.7% respectively p < 0.001,). No statistically significant difference was found between the ER and RR groups regarding pathological upgrade (39.7% vs. 24.2% respectively, p = 0.130). In the logistic regression analysis performed to determine the factors predicting ciPC, decreased prostate volume and ER system use were found to be independent predictive factors.

CONCLUSION

While the detection rate of csPC was similar for the RR and ER systems, the detection rate of all cancers and ciPC was significantly higher with the ER systems.

摘要

背景/目的:本研究旨在通过匹配分析,比较基于软件的靶向前列腺活检(TPB)中刚性配准(RR)和弹性配准(ER)系统在诊断所有癌症及临床显著前列腺癌(csPC)方面的成功率。

材料与方法

使用了来自六个进行基于软件的TPB的中心的2061例患者的数据。采用倾向得分卡尺法进行马氏距离匹配后,比较RR和ER系统的所有癌症及csPC检测率。应用逻辑回归分析确定预测临床意义不显著前列腺癌(ciPC)和csPC诊断的因素。此外,比较了活检和前列腺癌根治术病理中RR和ER系统的国际泌尿病理学会分级组(ISUP GG)升级率。

结果

匹配样本包括157例RR患者和157例ER患者。在csPC检测率方面,ER和RR之间未发现统计学显著差异(分别为28.0%和22.3%,p = 0.242)。发现ER相比RR的所有癌症检测率显著更高(分别为54.8%和35.7%,p < 0.001)。在病理升级方面,ER组和RR组之间未发现统计学显著差异(分别为39.7%和24.2%,p = 0.130)。在确定预测ciPC的因素的逻辑回归分析中,发现前列腺体积减小和使用ER系统是独立预测因素。

结论

虽然RR和ER系统的csPC检测率相似,但ER系统的所有癌症和ciPC检测率显著更高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e7f/11673674/fd312b8ce1e4/tjmed-54-06-1327f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e7f/11673674/fd312b8ce1e4/tjmed-54-06-1327f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e7f/11673674/fd312b8ce1e4/tjmed-54-06-1327f1.jpg

相似文献

1
Comparison of rigid and elastic registration methods in software-based targeted prostate biopsy: a multicenter cohort study.基于软件的靶向前列腺活检中刚性与弹性配准方法的比较:一项多中心队列研究
Turk J Med Sci. 2024 Sep 3;54(6):1327-1334. doi: 10.55730/1300-0144.5916. eCollection 2024.
2
A Multicentre Analysis of the Detection of Clinically Significant Prostate Cancer Following Transperineal Image-fusion Targeted and Nontargeted Systematic Prostate Biopsy in Men at Risk.多中心分析经会阴影像融合靶向与非靶向系统前列腺活检在高危男性中检测临床显著前列腺癌的结果。
Eur Urol Oncol. 2020 Jun;3(3):262-269. doi: 10.1016/j.euo.2019.03.005. Epub 2019 Mar 29.
3
Comparison of transperineal and transrectal targeted prostate biopsy using Mahalanobis distance matching within propensity score caliper method: A multicenter study of Turkish Urooncology Association.采用倾向性评分卡尺内马氏距离匹配法比较经会阴和经直肠靶向前列腺活检:土耳其泌尿肿瘤协会的一项多中心研究。
Prostate. 2022 Mar;82(4):425-432. doi: 10.1002/pros.24288. Epub 2021 Dec 20.
4
Comparison of prostate cancer detection rates in patients undergoing MRI/TRUS fusion prostate biopsy with two different software-based systems.使用两种不同基于软件的系统对接受MRI/TRUS融合前列腺活检的患者进行前列腺癌检测率的比较。
Prostate. 2022 Feb;82(2):227-234. doi: 10.1002/pros.24264. Epub 2021 Nov 3.
5
Pathological findings at radical prostatectomy of biopsy naïve men diagnosed with MRI targeted biopsy alone without concomitant standard systematic sampling.MRI 靶向活检单独诊断而无伴随标准系统抽样的活检初筛男性行根治性前列腺切除术的病理发现。
Urol Oncol. 2020 Dec;38(12):929.e11-929.e19. doi: 10.1016/j.urolonc.2020.05.027. Epub 2020 Jun 26.
6
Should Targeted Biopsy be Performed in Patients Who Have Only Pi-rads 3 Lesions?仅存在 PI-RADS 3 类病灶的患者是否应行靶向活检?
Arch Esp Urol. 2022 Jun;75(5):410-415. doi: 10.37554/en-j.arch.esp.urol-20210717-3506-26.
7
Fusion-targeted biopsy significantly improves prostate cancer detection in biopsy-naïve men.融合靶向活检显著提高了初次活检的前列腺癌检出率。
Int J Urol. 2023 Jul;30(7):600-604. doi: 10.1111/iju.15188. Epub 2023 Apr 20.
8
Detection of Clinically Significant Prostate Cancer Using Targeted Biopsy with Four Cores Versus Target Saturation Biopsy with Nine Cores in Transperineal Prostate Fusion Biopsy: A Prospective Randomized Trial.经会阴前列腺融合活检中,使用 4 针靶向活检与 9 针靶向饱和活检检测临床显著前列腺癌:一项前瞻性随机试验。
Eur Urol Oncol. 2023 Feb;6(1):49-55. doi: 10.1016/j.euo.2022.08.005. Epub 2022 Sep 26.
9
PI-RADS Version 2.0 Versus Version 2.1: Comparison of Prostate Cancer Gleason Grade Upgrade and Downgrade Rates From MRI-Targeted Biopsy to Radical Prostatectomy.PI-RADS 版本 2.0 与版本 2.1:从 MRI 靶向活检到根治性前列腺切除术的前列腺癌 Gleason 分级升级和降级率比较。
AJR Am J Roentgenol. 2024 Jan;222(1):e2329964. doi: 10.2214/AJR.23.29964. Epub 2023 Sep 20.
10
Comparison in Detection Rate of Clinically Significant Prostate Cancer Between Microultrasound-guided Prostate Biopsy (ExactVu) and Multiparametric Resonance Imaging-guided Prostate Biopsy (Koelis System).微超声引导前列腺活检(ExactVu)与多参数磁共振成像引导前列腺活检(Koelis 系统)在检测临床显著前列腺癌方面的比较。
Urology. 2024 Jan;183:163-169. doi: 10.1016/j.urology.2023.09.049. Epub 2023 Oct 30.

本文引用的文献

1
Diagnostic performance of fusion (US/MRI guided) prostate biopsy: propensity score matched comparison of elastic versus rigid fusion system.融合(超声/磁共振引导)前列腺活检的诊断性能:弹性与刚性融合系统的倾向评分匹配比较。
World J Urol. 2022 Apr;40(4):991-996. doi: 10.1007/s00345-021-03921-0. Epub 2022 Jan 17.
2
Comparison of prostate cancer detection rates in patients undergoing MRI/TRUS fusion prostate biopsy with two different software-based systems.使用两种不同基于软件的系统对接受MRI/TRUS融合前列腺活检的患者进行前列腺癌检测率的比较。
Prostate. 2022 Feb;82(2):227-234. doi: 10.1002/pros.24264. Epub 2021 Nov 3.
3
Comparison of Accuracies between Real-Time Nonrigid and Rigid Registration in the MRI-US Fusion Biopsy of the Prostate.
前列腺MRI-US融合活检中实时非刚性与刚性配准准确性的比较。
Diagnostics (Basel). 2021 Aug 16;11(8):1481. doi: 10.3390/diagnostics11081481.
4
Usability and diagnostic accuracy of different MRI/ultrasound-guided fusion biopsy systems for the detection of clinically significant and insignificant prostate cancer: a prospective cohort study.不同 MRI/超声引导融合活检系统在检测临床显著和不显著前列腺癌中的可用性和诊断准确性:一项前瞻性队列研究。
World J Urol. 2021 Nov;39(11):4101-4108. doi: 10.1007/s00345-021-03761-y. Epub 2021 Jun 17.
5
How does a prebiopsy mri approach for prostate cancer diagnosis affect prostatectomy upgrade rates?前列腺癌诊断的活检前 MRI 方法如何影响前列腺切除术的升级率?
Urol Oncol. 2021 Nov;39(11):784.e11-784.e16. doi: 10.1016/j.urolonc.2021.03.014. Epub 2021 Apr 16.
6
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.EAU-EANM-ESTRO-ESUR-SIOG 前列腺癌指南-2020 版更新。第 1 部分:筛查、诊断和以治愈为目的的局部治疗。
Eur Urol. 2021 Feb;79(2):243-262. doi: 10.1016/j.eururo.2020.09.042. Epub 2020 Nov 7.
7
Comparison of TRUS and combined MRI-targeted plus systematic prostate biopsy for the concordance between biopsy and radical prostatectomy pathology.TRUS 与 MRI 靶向联合系统前列腺活检在活检与根治性前列腺切除术病理一致性方面的比较。
Int J Clin Pract. 2021 Mar;75(3):e13797. doi: 10.1111/ijcp.13797. Epub 2020 Nov 20.
8
PI-RADS: Past, present, and future.PI-RADS:过去、现在和未来。
J Magn Reson Imaging. 2020 Jul;52(1):33-53. doi: 10.1002/jmri.26896. Epub 2019 Aug 8.
9
The REDCap consortium: Building an international community of software platform partners.REDCap 联盟:构建软件平台合作伙伴的国际社区。
J Biomed Inform. 2019 Jul;95:103208. doi: 10.1016/j.jbi.2019.103208. Epub 2019 May 9.
10
Comparison of Elastic and Rigid Registration during Magnetic Resonance Imaging/Ultrasound Fusion-Guided Prostate Biopsy: A Multi-Operator Phantom Study.磁共振成像/超声融合引导前列腺活检中弹性和刚性配准的比较:多操作者体模研究。
J Urol. 2018 Nov;200(5):1114-1121. doi: 10.1016/j.juro.2018.06.028. Epub 2018 Jun 22.